No Data
No Data
No Data
No Data
No Data
PainReform Announces Closing of $4 Million Public Offering
TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established
GlobeNewswireApr 19 02:19
PainReform Ltd. Adjusts Warrant Terms
TipRanksApr 18 04:57
PainReform Prices Its $4M Offering at $0.80 Apiece; Shares Fall
Seeking AlphaApr 16 20:10
PainReform Prices Offering Of 5M Shares And Warrants At $0.80/Share And Accompanying Warrant
PainReform Prices Offering Of 5M Shares And Warrants At $0.80/Share And Accompanying Warrant
BenzingaApr 16 20:03
PainReform to Issue 5M Ordinary Shares, and Warrants to Purchase Up to 5M Shares, at 80 Cents>PRFX
PainReform to Issue 5M Ordinary Shares, and Warrants to Purchase Up to 5M Shares, at 80 Cents>PRFX
Dow JonesApr 16 20:03
PainReform Will Use Proceeds To Advance Clinical Studies, General Corporate Purposes >PRFX
PainReform Will Use Proceeds To Advance Clinical Studies, General Corporate Purposes >PRFX
Dow JonesApr 16 20:03
No Data
No Data